Create a free Feed Strategy account to continue reading

Testing of ASF vaccine candidates begins

A leading research institute in Kenya has initiated trials to test the efficacy of the first candidate African swine fever vaccines.

ASF-vaccine-in-development
dusanpetkovic | iStock.com

Key to gaining control over African swine fever (ASF) is the development of an effective vaccine against the disease, according to Lucilla Steinaa of the International Livestock Research Institute (ILRI) of Nairobi.

Testing of 10 vaccine candidates has just begun, reports China-based news agency, Xinhua. Efficacy will be evaluated against the virus genotype circulating in central and eastern Africa.

At the end of last year, ILRI announced that it had used cutting-edge technology to accelerate the development of ASF vaccines. The technology — clustered regularly interspaced short palindromic repeats, CRISPR — was being applied to fast-track the development of live-attenuated ASF virus vaccine candidates. Using CRISPR, ILRI scientists had identified the vaccine candidates in a little over one year, while older techniques might have needed five years to reach the same point.